DrugVisual

DrugVisual provides reliable, accurate, and up-to-date information reports about drugs and vaccines.

[DrugVisual @drug_visual]

Insilico Medicine Announces IND Approval of Oral 3CLpro Inhibitor ISM3312 for COVID-19 https://t.co/2YDHTJuUrP

[DrugVisual @drug_visual]

FDA Grants Priority Review to New Drug Application for Talazoparib, Enzalutamide in mCRPC https://t.co/pxly6ZlEUs

[DrugVisual @drug_visual]

A genetic test to predict adverse drug reactions https://t.co/yUCtPYLoHc

[DrugVisual @drug_visual]

China’s first domestically produced antidepressant approved for market sale. #Ruoxinlin #Toludesvenlafaxine hydrochloride https://t.co/34NdsBeCaH

[DrugVisual @drug_visual]

Apellis Pharmaceuticals, Inc. - FDA Approves SYFOVRE as the First and Only Treatment for Geographic Atrophy, a Leading Cause of Blindness https://t.co/hHcqsP5Z8C

[DrugVisual @drug_visual]

First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission https://t.co/uW4d9S73RM

[DrugVisual @drug_visual]

NIH Uncovers Racial Disparities in Long COVID Symptoms, Diagnosis Rates https://t.co/wjL6ioUxnS

[DrugVisual @drug_visual]

Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents https://t.co/2CJEgaMmaH

[DrugVisual @drug_visual]

CanSino Biologics : Latest Study Shows Encouraging Results of CanSinoBIO's mRNA COVID-19 Vaccine as Heterologous Booster | MarketScreener https://t.co/hmZpghd40v

[DrugVisual @drug_visual]

29 year old, who died from heart inflammation, is Singapore's first fatality related to COVID-19 vaccination. https://t.co/18robXb6YS

[DrugVisual @drug_visual]

Chest CTs Reveal Abnormalities 2 Years After Severe COVID https://t.co/yadXrthYfc

[DrugVisual @drug_visual]

Paxlovid Reduced Hospitalizations, Deaths During Omicron #paxlovid #omicron https://t.co/9Jf7WkeEeY

[DrugVisual @drug_visual]

Vaccination Could Reduce Risk of Long COVID, Study Shows ##LongCovidhttps://www.webmd.com/vaccines/covid-19-vaccine/news/20230215/vaccination-could-reduce-risk-of-long-covid

[DrugVisual @drug_visual]

NICE says evidence that COVID-19 treatment Evusheld is effective in protecting vulnerable adults against current variants is lacking. #Evusheld #NICE #Covid19 https://t.co/0GXbARF6XC

[Céline Gounder, MD, ScM, FIDSA 🇺🇦 @celinegounder]

1/ A recent study from Cedars Sinai Hospital shows the number of heart🫀attack deaths💀among people 25-44 years old during the first 2 years of the COVID pandemic was ‼️30% higher‼️ than predicted.

with @CBSNews' @tonydokoupil & @lilialuciano

https://t.co/yPJs5bebn1

[DrugVisual @drug_visual]

FDA Approves Pfizer's Supplemental New Drug Application for #CIBINQO® (#abrocitinib) #Atopicdermatitis
https://t.co/8kkhQY4Zir

[DrugVisual @drug_visual]

US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer #jemperli #endometrialcancer https://t.co/FIetLYgxJA

[DrugVisual @drug_visual]

FDA clears test to detect multiple respiratory infections, including COVID-19  https://t.co/H6P2B6HnTU

[DrugVisual @drug_visual]

WHO kicks off deliberations on ethical framework and tools for social listening and infodemic management #sociallistening #infodemicmanagement #WHO https://t.co/RLR4RqO97h

[DrugVisual @drug_visual]

China says it is actively sharing COVID-related information with WHO https://t.co/U0huGHx4gB